Results 51 to 60 of about 7,787,676 (175)

Distribution and attribution of high-risk human papillomavirus genotypes in cervical precancerous lesions in China

Tumor Biology, 2017
While human papillomavirus vaccine was recently approved by China Food and Drug Administration, mapping of high-risk human papillomavirus distribution and attribution in cervical precancerous lesions in China becomes critical in development of a high ...
Wenpeng Wang, Jusheng An, Yan Song, Minjie Wang, Manni Huang, Lingying Wu   +5 more
doaj   +1 more source

Knowledge, Attitude, And Factors Affecting Human Papilloma Virus Vaccine Uptake Among Female Undergraduate Students In Public Tertiary Institutions In Lagos State Nigeria.

International Journal of Medical Students, 2023
BACKGROUND: Human Papillomavirus is responsible for about 99% of all cervical cancers. Cervical cancer remains a leading cause of morbidity and mortality in women from Low and middle-income countries. Vaccination against human papillomavirus (HPV) is an
Elile Monisola Okoka, Joshua Olufisayo Odeyemi, Mariam Ajoke Olu-Ajayi   +2 more
doaj   +1 more source

The T‐Cell Response Mechanism in Human Papillomavirus‐Associated Cervical Cancer and New Strategies for Immunotherapy

iNew Medicine, EarlyView.
ABSTRACT Human papillomavirus (HPV) is a double‐stranded DNA virus that infects human skin and mucosal tissues exclusively. The German scientist Harald zur Hausen was awarded the 2008 Nobel Prize in Physiology or Medicine for his discovery of the link between HPV infection and cervical cancer.
Fang Zhu, Farah Nazir, Ying Zhou, Yuhua Shang, Hongliang He, Tengchuan Jin   +5 more
wiley   +1 more source

A multinational cross-sectional study on human papillomavirus and cervical cancer knowledge, vaccination attitudes, and risk factors in the Middle East

Scientific Reports
Human papillomavirus is the most common viral sexually transmitted infection worldwide and affects individuals of all ages and both sexes. It is also the most preventable cause of cervical cancer.
Ahmed A.Amer, Hashem Altabbaa, Mohamed Sh. Ramadan, Hamza A. Abdul-Hafez, Hanaa S. Said, Misha Khan, Mohammed Musaed Al-Jabri, Dana jihad haj-salim, Qusai Razzouk, Mohamed A.S. Amer, Samar A. Amer, Data Collector Group   +11 more
doaj   +1 more source

Therapeutic Vaccine Strategies against Human Papillomavirus

Vaccines, 2014
High-risk types of human papillomavirus (HPV) cause over 500,000 cervical, anogenital and oropharyngeal cancer cases per year. The transforming potential of HPVs is mediated by viral oncoproteins.
Hadeel Khallouf, Agnieszka K. Grabowska, Angelika B. Riemer   +2 more
doaj   +1 more source

Immunogenicity of bivalent human papillomavirus DNA vaccine using human endogenous retrovirus envelope-coated baculoviral vectors in mice and pigs. [PDF]

PLoS ONE, 2012
Human papillomavirus is known to be the major pathogen of cervical cancer. Here, we report the efficacy of a bivalent human papillomavirus type 16 and 18 DNA vaccine system following repeated dosing in mice and pigs using a recombinant baculovirus ...
Hee-Jung Lee, Yoon-Ki Hur, Youn-Dong Cho, Mi-Gyeong Kim, Hoon-Taek Lee, Yu-Kyoung Oh, Young Bong Kim   +6 more
doaj   +1 more source

Low Uptake of the Second Dose of Human Papillomavirus Vaccine in Dar es Salaam, Tanzania

Vaccines, 2022
Cervical cancer represents the most common neoplastic pathology among women, with a high burden of morbidity and mortality globally. Tanzania is no exception.
Nchang’wa Nhumba, Bruno Sunguya
doaj   +1 more source

Preliminary Development and Assessment of a Multiplex Assay for Human Papillomavirus Antibody Detection Using Commercial L1 Proteins

Journal of Clinical Laboratory Analysis, EarlyView.
This study developed and assessed a new multiplex assay for the simultaneous detection of antibodies against multiple Human Papillomavirus (HPV) types. Using recombinant L1 protein, the assay quantifies IgG and IgA responses in human plasma, enabling comprehensive immune profiling across multiple high‐risk cancer‐associated HPV genotypes. This approach
Arash Aslanabadi, Maryam Karimi, Laura Powell, Lisa Schumaker, Ashley Shutt, Mahsa Hojabri, Rahim Abbasi, Søren M. Bentzen, Kevin J. Cullen, Trevor A. Crowell, Rebecca G. Nowak, Mohammad M. Sajadi   +11 more
wiley   +1 more source

Temporal Trends in Cervical Human Papillomavirus Prevalence Among Females in Xiamen, China (2016-2023): Cross-Sectional Study

JMIR Public Health and Surveillance
BackgroundHuman papillomavirus (HPV) is a primary causative agent of cervical cancer, accounting for more than 90% of cases worldwide. Epidemiological data on regional HPV prevalence and genotype distribution are critical for tailoring targeted cervical ...
Zhuju Chen, Erjuan Lin, Mo Chen, Shihan Wang, Qiuyuan Lin, Qingquan Chen, Heng Xue, Guanbin Zhang   +7 more
doaj   +1 more source

Trends in hospitalizations for vaccine‐preventable diseases in the United States from 2014 to 2024

Journal of Hospital Medicine, EarlyView.
Abstract Background and Objectives Vaccination rates have declined in recent years, resulting in outbreaks of vaccine‐preventable diseases (VPDs) among children. We aimed to evaluate VPD hospitalization rates from 2014 to 2024 and to report associated trends in outcomes including intensive care utilization, mortality, readmissions, and costs.
Nathan M. Money, Erin Sullivan, Hannah Rector, Corrie E. McDaniel, Jessica L. Markham, Mersine A. Bryan   +5 more
wiley   +1 more source